Sex Differences in Portopulmonary Hypertension
Authors:
- Hilary M. DuBrockHDHilary M. DuBrock
- Rodrigo Cartin-CebaRCRodrigo Cartin-Ceba
- Richard N. ChannickRCRichard N. Channick
- Steven M. KawutSKSteven M. Kawut
- Michael J. KrowkaMKMichael J. Krowka
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
This publication has 32 references indexed in Scilit:
- Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease eraLiver Transplantation, 2011
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Determinants of Right Ventricular Ejection Fraction in Pulmonary Arterial HypertensionChest, 2009
- Clinical risk factors for portopulmonary hypertension†Hepatology, 2008
- Model for end-stage liver disease (MELD) exception for portopulmonary hypertensionLiver Transplantation, 2006
- Pulmonary Arterial Hypertension in FranceAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Hemodynamics and Survival of Patients With Portopulmonary HypertensionLiver Transplantation, 2005
- Estradiol metabolism in cirrhosisJournal of Clinical Investigation, 1968